The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. ...
Jun 21, 2023
0
2
A few years ago, celebrity weight-control practices were out of most people's reach. Live-in chefs and personal trainers, not to mention elaborate surgical procedures like the Brazilian butt lift, were not real options for ...
Jun 19, 2023
0
3
Adults at high cardiovascular risk and living with overweight or obesity experience a higher number of cardiovascular events (such as heart attack and stroke), are at greater risk of dying prematurely, and have considerably ...
May 17, 2023
0
2
Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.
May 5, 2023
0
2
Pharmaceutical giant Eli Lilly said Thursday it will seek approval to add its diabetes drug to the buzzy US weight loss market after achieving promising results in a new clinical trial.
Apr 27, 2023
0
2
Suzette Zuena is her own best advertisement for weight loss. Zuena, the "founder/visionary" of LH Spa & Rejuvenation in Livingston and Madison, New Jersey, has dropped 30 pounds. Her husband has lost 42 pounds.
Apr 20, 2023
0
37
In early March, Eli Lilly made headlines after announcing a new $35 price cap on insulin for individuals with private insurance. Novo Nordisk and Sanofi made their own price reduction announcements shortly after Eli Lilly's ...
Mar 18, 2023
0
31
French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two other major drug makers.
Mar 17, 2023
0
2
Doctors have criticized the General Medical Council (GMC) after The BMJ found it had investments in fast food firms, pharmaceutical companies, private medical insurers and private healthcare providers.
Mar 15, 2023
0
3
Novo Nordisk announced Tuesday that it will lower the US price of insulin by up to 75 percent, the latest move by a drugmaker to mitigate diabetes treatment costs.
Mar 14, 2023
0
1
